Cas 225779-17-9,Carbamic acid, [(1S)-1-(hydroxymethyl)-4-pentenyl]-, 1,1-dimethylethyl ester

225779-17-9

Post Buying Request

Basic information

Product Name: Carbamic acid, [(1S)-1-(hydroxymethyl)-4-pentenyl]-, 1,1-dimethylethyl ester
Synonyms: Carbamic acid, [(1S)-1-(hydroxymethyl)-4-pentenyl]-, 1,1-dimethylethyl ester
CAS NO:225779-17-9
Molecular Formula: C11H21NO3
Molecular Weight: 215.28934
EINECS: N/A
Product Categories: N-BOC
Mol File: 225779-17-9.mol

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: /
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Carbamic acid, [(1S)-1-(hydroxymethyl)-4-pentenyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: Carbamic acid, [(1S)-1-(hydroxymethyl)-4-pentenyl]-, 1,1-dimethylethyl ester(225779-17-9)
EPA Substance Registry System: Carbamic acid, [(1S)-1-(hydroxymethyl)-4-pentenyl]-, 1,1-dimethylethyl ester(225779-17-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 225779-17-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

225779-17-9 Suppliers

Recommended suppliers

225779-17-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 225779-17-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,5,7,7 and 9 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 225779-17:
(8*2)+(7*2)+(6*5)+(5*7)+(4*7)+(3*9)+(2*1)+(1*7)=159
159 % 10 = 9
So 225779-17-9 is a valid CAS Registry Number.

225779-17-9Upstream product

225779-17-9Downstream Products

225779-17-9Relevant academic research and scientific papers

MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY

-

Page/Page column 36; 38; 39, (2020/11/04)

The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts, solvates, hydrates, tautomers or stereoisomers thereof, wherein R1 to R3, A1 and A2 have the meaning as indicated in the description and claims. The invention further relates to pharmaceutical compositions comprising said compounds, their use as medicament and in a method for treating and preventing one or more diseases or disorders associated with integrated stress response.

MODULATORS OF THE INTEGRATED STRESS PATHWAY

-

Page/Page column 165-166, (2019/05/22)

Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.

Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activity

Surivet, Jean-Philippe,Zumbrunn, Cornelia,Rueedi, Georg,Hubschwerlen, Christian,Bur, Daniel,Bruyère, Thierry,Locher, Hans,Ritz, Daniel,Keck, Wolfgang,Seiler, Peter,Kohl, Christopher,Gauvin, Jean-Christophe,Mirre, Azely,Kaegi, Verena,Dos Santos, Marina,Gaertner, Mika,Delers, Jonathan,Enderlin-Paput, Michel,Boehme, Maria

, p. 7396 - 7415 (2013/10/21)

There is an urgent need for new antibacterial drugs that are effective against infections caused by multidrug-resistant pathogens. Novel nonfluoroquinolone inhibitors of bacterial type II topoisomerases (DNA gyrase and topoisomerase IV) have the potential

ANTIBIOTIC COMPOUNDS

-

Page/Page column 31-32, (2010/11/28)

The invention relates to selected antibiotics of formula (Al) wherein R1 represents alkyl, alkoxy, haloalkoxy, halogen or cyano; one or two of U, V, W and X represent(s) N, the remaining represent CH, or, in case of U, V and/or W, may also repr

A concise synthesis of (+)-α-allokainic acid via site- and diastereoselective intramolecular C-H insertion process

Anada, Masahiro,Sugimoto, Tomohiro,Watanabe, Nobuhide,Nakajima, Makoto,Hashimoto, Shun-Ichi

, p. 969 - 980 (2007/10/03)

A new route to (+)-α-allokainic acid commencing with L-serine has been established, wherein the key step involves a C3-C4 bond formation with a simultaneous creation of a C2, C3-trans and C3, C4-trans arrangement of substituents by Rh2(OAc)4-catalyzed C-H insertion reaction of α- diazoacetoacetamide tethered to (S)-4-(3-butenyl)-2,2-dimethyl-1,3- oxazolidine system. Taber's computational model confirms the observed diastereomer preference.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 225779-17-9